BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, Schüttrumpf L, Ernst A, Niemöller OM, Belka C. Current concepts in clinical radiation oncology. Radiat Environ Biophys 2014;53:1-29. [PMID: 24141602 DOI: 10.1007/s00411-013-0497-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Grote M, Maihöfer C, Weigl M, Davies-Knorr P, Belka C. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial. Radiat Oncol 2018;13:215. [PMID: 30400971 DOI: 10.1186/s13014-018-1157-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
2 D'Andrea MA, Reddy GK. Brain Radiation Induced Extracranial Abscopal Effects in Metastatic Melanoma. Am J Clin Oncol 2020;43:836-45. [PMID: 33044231 DOI: 10.1097/COC.0000000000000760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Podolska MJ, Shan X, Janko C, Boukherroub R, Gaipl US, Szunerits S, Frey B, Muñoz LE. Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death. Front Oncol 2021;11:664615. [PMID: 34485114 DOI: 10.3389/fonc.2021.664615] [Reference Citation Analysis]
4 Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, Zheng W, Mauceri H, Mack M, Xu M, Fu YX, Weichselbaum RR. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun 2017;8:1736. [PMID: 29170400 DOI: 10.1038/s41467-017-01566-5] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 27.0] [Reference Citation Analysis]
5 Unkel S, Belka C, Lauber K. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model. Radiat Oncol 2016;11:11. [PMID: 26822015 DOI: 10.1186/s13014-016-0584-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
6 Scheithauer H, Belka C, Lauber K, Gaipl US. Immunological aspects of radiotherapy. Radiat Oncol 2014;9:185. [PMID: 25142149 DOI: 10.1186/1748-717X-9-185] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
7 Roy A, Datta S, Bhatia KS, Bhumika, Jha P, Prasad R. Role of plant derived bioactive compounds against cancer. South African Journal of Botany 2021. [DOI: 10.1016/j.sajb.2021.10.015] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chiarelli PA, Revia RA, Stephen ZR, Wang K, Kievit FM, Sandhu J, Upreti M, Chung S, Ellenbogen RG, Zhang M. Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.04.001] [Reference Citation Analysis]
9 Deloch L, Derer A, Hartmann J, Frey B, Fietkau R, Gaipl US. Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Front Oncol 2016;6:141. [PMID: 27379203 DOI: 10.3389/fonc.2016.00141] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 13.3] [Reference Citation Analysis]
10 Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, Reichel CA, Frey B, Gaipl US, Winssinger N, Shirasawa S, Sasazuki T, Sperandio M, Belka C, Lauber K. Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90. Front Oncol 2020;10:1668. [PMID: 32984042 DOI: 10.3389/fonc.2020.01668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Frey B, Rückert M, Weber J, Mayr X, Derer A, Lotter M, Bert C, Rödel F, Fietkau R, Gaipl US. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors. Front Immunol 2017;8:231. [PMID: 28337197 DOI: 10.3389/fimmu.2017.00231] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
12 Unger K. Integrative radiation systems biology. Radiat Oncol 2014;9:21. [PMID: 24411063 DOI: 10.1186/1748-717X-9-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
13 Osei E, Francis R, Mohamed A, Sheraz L, Soltani-mayvan F. Impact of COVID-19 pandemic on the oncologic care continuum: urgent need to restore patients care to pre-COVID-19 era. J Radiother Pract. [DOI: 10.1017/s1460396921000303] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 D’andrea MA, Reddy GK. Extracranial Abscopal Effects Induced by Brain Radiation in Advanced Lung Cancer. American Journal of Clinical Oncology 2019;42:951-7. [DOI: 10.1097/coc.0000000000000623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R, Frey B, Fietkau R, Gaipl US. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat Oncol 2014;9:89. [PMID: 24678590 DOI: 10.1186/1748-717X-9-89] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
16 Mohan G, T P AH, A J J, K M SD, Narayanasamy A, Vellingiri B. Recent advances in radiotherapy and its associated side effects in cancer—a review. JoBAZ 2019;80. [DOI: 10.1186/s41936-019-0083-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
17 Hennel R, Brix N, Seidl K, Ernst A, Scheithauer H, Belka C, Lauber K. Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation. Radiat Oncol 2014;9:85. [PMID: 24666643 DOI: 10.1186/1748-717X-9-85] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
18 Kuchur OA, Kuzmina DO, Dukhinova MS, Shtil AA. The p53 Protein Family in the Response of Tumor Cells to Ionizing Radiation: Problem Development. Acta Naturae 2021;13:65-76. [PMID: 34707898 DOI: 10.32607/actanaturae.11247] [Reference Citation Analysis]
19 Potez M, Bouchet A, Wagner J, Donzelli M, Bräuer-Krisch E, Hopewell JW, Laissue J, Djonov V. Effects of Synchrotron X-Ray Micro-beam Irradiation on Normal Mouse Ear Pinnae. Int J Radiat Oncol Biol Phys 2018;101:680-9. [PMID: 29559293 DOI: 10.1016/j.ijrobp.2018.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
20 Yu P, Han X, Yin L, Hui K, Guo Y, Yuan A, Hu Y, Wu J. Artificial Red Blood Cells Constructed by Replacing Heme with Perfluorodecalin for Hypoxia‐Induced Radioresistance. Adv Therap 2019;2:1900031. [DOI: 10.1002/adtp.201900031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
21 Zhao X, Kang J, Zhao R. Abscopal effect of radiation on lymph node metastasis in esophageal carcinoma: A case report and literature review. Oncol Lett 2018;16:3555-60. [PMID: 30127961 DOI: 10.3892/ol.2018.9084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Podolska MJ, Barras A, Alexiou C, Frey B, Gaipl U, Boukherroub R, Szunerits S, Janko C, Muñoz LE. Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death. Cells 2020;9:E776. [PMID: 32209981 DOI: 10.3390/cells9030776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
23 Yu S, Wang Y, He P, Shao B, Liu F, Xiang Z, Yang T, Zeng Y, He T, Ma J, Wang X, Liu L. Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment. Front Oncol 2022;12:809304. [DOI: 10.3389/fonc.2022.809304] [Reference Citation Analysis]
24 Tian W, Cao C, Shu L, Wu F. Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer. Onco Targets Ther 2020;13:12113-29. [PMID: 33262610 DOI: 10.2147/OTT.S276150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 de Leve S, Wirsdörfer F, Jendrossek V. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects. Cancers (Basel) 2019;11:E1578. [PMID: 31623231 DOI: 10.3390/cancers11101578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Werthmöller N, Frey B, Rückert M, Lotter M, Fietkau R, Gaipl US. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo. International Journal of Hyperthermia 2016;32:23-30. [DOI: 10.3109/02656736.2015.1106011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
27 Spetz J, Rudqvist N, Langen B, Parris TZ, Dalmo J, Schüler E, Wängberg B, Nilsson O, Helou K, Forssell-Aronsson E. Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy. Nucl Med Biol 2018;60:11-8. [PMID: 29502008 DOI: 10.1016/j.nucmedbio.2018.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
28 Lauber K, Brix N, Ernst A, Hennel R, Krombach J, Anders H, Belka C. Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity. Cancer Letters 2015;368:209-29. [DOI: 10.1016/j.canlet.2015.02.047] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
29 Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo) 2018;73:e557s. [PMID: 30540123 DOI: 10.6061/clinics/2018/e557s] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
30 D’andrea MA, Reddy GK. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy. American Journal of Clinical Oncology 2020;43:218-28. [DOI: 10.1097/coc.0000000000000651] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xie X, Xu Z, Wang C, Fang C, Zhao J, Xu L, Qian X, Dai J, Sun F, Xu D, He W. Tip60 is associated with resistance to X-ray irradiation in prostate cancer. FEBS Open Bio 2018;8:271-8. [PMID: 29435417 DOI: 10.1002/2211-5463.12371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Ernst A, Anders H, Kapfhammer H, Orth M, Hennel R, Seidl K, Winssinger N, Belka C, Unkel S, Lauber K. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas. Cancer Lett 2015;365:211-22. [PMID: 26044951 DOI: 10.1016/j.canlet.2015.05.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
33 Zhou R, Yan L, Dong X, Zhu S, Chen K, Wu Y, Xiang H, Li L, Zhang G, Gu Z, Zhao Y. Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost. Nano Today 2021;36:101003. [DOI: 10.1016/j.nantod.2020.101003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers (Basel) 2020;12:E957. [PMID: 32294976 DOI: 10.3390/cancers12040957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Tsai TL, Lai YH, Hw Chen H, Su WC. Overcoming Radiation Resistance by Iron-Platinum Metal Alloy Nanoparticles in Human Copper Transport 1-Overexpressing Cancer Cells via Mitochondrial Disturbance. Int J Nanomedicine 2021;16:2071-85. [PMID: 33727814 DOI: 10.2147/IJN.S283147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Roh C. Metabolomics in Radiation-Induced Biological Dosimetry: A Mini-Review and a Polyamine Study. Biomolecules 2018;8:E34. [PMID: 29844258 DOI: 10.3390/biom8020034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
37 Gadwa J, Karam SD. Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer. Int J Radiat Oncol Biol Phys 2020;108:46-55. [PMID: 32629082 DOI: 10.1016/j.ijrobp.2020.06.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Allison RR, Patel RM, Mclawhorn RA. Radiation oncology: physics advances that minimize morbidity. Future Oncology 2014;10:2329-44. [DOI: 10.2217/fon.14.176] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
39 Wang W, Tse-Dinh YC. Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy. Curr Top Med Chem 2019;19:730-40. [PMID: 30931861 DOI: 10.2174/1568026619666190401113350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
40 Dünker N, Jendrossek V. Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research. Cancers (Basel) 2019;11:E1499. [PMID: 31591362 DOI: 10.3390/cancers11101499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
41 De Felice M, Tammaro M, Leopardo D, Ianniello GP, Turitto G. Moving towards the Future of Radio-Immunotherapy: Could We “Tailor” the Abscopal Effect on Head and Neck Cancer Patients? Immuno 2021;1:410-23. [DOI: 10.3390/immuno1040029] [Reference Citation Analysis]
42 Brix N, Tiefenthaller A, Anders H, Belka C, Lauber K. Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. Immunol Rev. 2017;280:249-279. [PMID: 29027221 DOI: 10.1111/imr.12573] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 21.0] [Reference Citation Analysis]
43 Tran TA, Kim YH, Duong TH, Jung S, Kim IY, Moon KS, Jang WY, Lee HJ, Lee JJ, Jung TY. Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model. Front Immunol 2020;11:1165. [PMID: 32733437 DOI: 10.3389/fimmu.2020.01165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 D’andrea MA, Reddy GK. The systemic immunostimulatory effects of radiation therapy producing overall tumor control through the abscopal effect. J Radiat Oncol 2019;8:143-56. [DOI: 10.1007/s13566-019-00391-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Zhang T, Yu H, Ni C, Zhang T, Liu L, Lv Q, Zhang Z, Wang Z, Wu D, Wu P, Chen G, Wang L, Wei Q, Huang J, Wang X. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer. Sci Rep 2017;7:4866. [PMID: 28687760 DOI: 10.1038/s41598-017-04978-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
46 Hess J, Unger K, Orth M, Schötz U, Schüttrumpf L, Zangen V, Gimenez-Aznar I, Michna A, Schneider L, Stamp R, Selmansberger M, Braselmann H, Hieber L, Drexler GA, Kuger S, Klein D, Jendrossek V, Friedl AA, Belka C, Zitzelsberger H, Lauber K. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. Cancer Lett 2017;386:87-99. [PMID: 27867017 DOI: 10.1016/j.canlet.2016.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
47 Klaus R, Niyazi M, Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol 2021;16:43. [PMID: 33632272 DOI: 10.1186/s13014-021-01764-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
48 Yun CW, Kim HJ, Lim JH, Lee SH. Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy. Cells 2019;9:E60. [PMID: 31878360 DOI: 10.3390/cells9010060] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
49 Pajuelo-Lozano N, Bargiela-Iparraguirre J, Dominguez G, Quiroga AG, Perona R, Sanchez-Perez I. XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells. Front Pharmacol 2018;9:1197. [PMID: 30386247 DOI: 10.3389/fphar.2018.01197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
50 Lauber K, Dunn L. Immunotherapy Mythbusters in Head and Neck Cancer: The Abscopal Effect and Pseudoprogression. American Society of Clinical Oncology Educational Book 2019. [DOI: 10.1200/edbk_238339] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
51 Weichselbaum RR, Liang H, Deng L, Fu Y. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol 2017;14:365-79. [DOI: 10.1038/nrclinonc.2016.211] [Cited by in Crossref: 394] [Cited by in F6Publishing: 381] [Article Influence: 78.8] [Reference Citation Analysis]
52 Samaga D, Hornung R, Braselmann H, Hess J, Zitzelsberger H, Belka C, Boulesteix AL, Unger K. Single-center versus multi-center data sets for molecular prognostic modeling: a simulation study. Radiat Oncol 2020;15:109. [PMID: 32410693 DOI: 10.1186/s13014-020-01543-1] [Reference Citation Analysis]
53 Krombach J, Hennel R, Brix N, Orth M, Schoetz U, Ernst A, Schuster J, Zuchtriegel G, Reichel CA, Bierschenk S, Sperandio M, Vogl T, Unkel S, Belka C, Lauber K. Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells. Oncoimmunology 2019;8:e1523097. [PMID: 30546963 DOI: 10.1080/2162402X.2018.1523097] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
54 Falcke SE, Rühle PF, Deloch L, Fietkau R, Frey B, Gaipl US. Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System. Int J Mol Sci 2018;19:E3574. [PMID: 30428512 DOI: 10.3390/ijms19113574] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
55 Mirzaei HR, Pourghadamyari H, Rahmati M, Mohammadi A, Nahand JS, Rezaei A, Mirzaei H, Hadjati J. Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy. Cancer Letters 2018;423:95-104. [DOI: 10.1016/j.canlet.2018.03.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
56 Salomon N, Vascotto F, Selmi A, Vormehr M, Quinkhardt J, Bukur T, Schrörs B, Löewer M, Diken M, Türeci Ö, Sahin U, Kreiter S. A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. Oncoimmunology 2020;9:1771925. [PMID: 32923128 DOI: 10.1080/2162402X.2020.1771925] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
57 Gaipl US, Multhoff G, Scheithauer H, Lauber K, Hehlgans S, Frey B, Rödel F. Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy. Immunotherapy 2014;6:597-610. [PMID: 24896628 DOI: 10.2217/imt.14.38] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
58 Katsuta E, Rashid OM, Takabe K. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models. Hum Cell 2020;33:930-7. [PMID: 32507979 DOI: 10.1007/s13577-020-00380-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
59 de Leve S, Wirsdörfer F, Jendrossek V. Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. Front Immunol 2019;10:698. [PMID: 31024543 DOI: 10.3389/fimmu.2019.00698] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
60 Jalalimanesh A, Haghighi HS, Ahmadi A, Hejazian H, Soltani M. Multi-objective optimization of radiotherapy: distributed Q-learning and agent-based simulation. Journal of Experimental & Theoretical Artificial Intelligence 2017;29:1071-86. [DOI: 10.1080/0952813x.2017.1292319] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
61 Dalmo J, Spetz J, Montelius M, Langen B, Arvidsson Y, Johansson H, Parris TZ, Helou K, Wängberg B, Nilsson O, Ljungberg M, Forssell-Aronsson E. Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1. EJNMMI Res 2017;7:6. [PMID: 28097640 DOI: 10.1186/s13550-016-0247-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
62 Yan D, Zhao Q, Du Z, Li H, Geng R, Yang W, Zhang X, Cao J, Yi N, Zhou J, Tang Z. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10601-5] [Reference Citation Analysis]
63 Kouam PN, Rezniczek GA, Adamietz IA, Bühler H. Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin. BMC Cancer 2019;19:958. [PMID: 31619190 DOI: 10.1186/s12885-019-6219-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
64 Sass S, Pitea A, Unger K, Hess J, Mueller NS, Theis FJ. MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2015;16:30204-22. [PMID: 26694379 DOI: 10.3390/ijms161226230] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
65 Menon SS, Uppal M, Randhawa S, Cheema MS, Aghdam N, Usala RL, Ghosh SP, Cheema AK, Dritschilo A. Radiation Metabolomics: Current Status and Future Directions. Front Oncol 2016;6:20. [PMID: 26870697 DOI: 10.3389/fonc.2016.00020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
66 Jalalimanesh A, Shahabi Haghighi H, Ahmadi A, Soltani M. Simulation-based optimization of radiotherapy: Agent-based modeling and reinforcement learning. Mathematics and Computers in Simulation 2017;133:235-48. [DOI: 10.1016/j.matcom.2016.05.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 5.2] [Reference Citation Analysis]
67 Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu L. microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells. Oncol Lett 2015;10:2055-62. [PMID: 26622795 DOI: 10.3892/ol.2015.3551] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
68 Szymonowicz K, Krysztofiak A, Linden JV, Kern A, Deycmar S, Oeck S, Squire A, Koska B, Hlouschek J, Vüllings M, Neander C, Siveke JT, Matschke J, Pruschy M, Timmermann B, Jendrossek V. Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining. Cells 2020;9:E889. [PMID: 32260562 DOI: 10.3390/cells9040889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
69 Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 2017;20:409-26. [PMID: 28660302 DOI: 10.1007/s10456-017-9562-9] [Cited by in Crossref: 341] [Cited by in F6Publishing: 349] [Article Influence: 68.2] [Reference Citation Analysis]
70 Jelonek K, Krzywon A, Jablonska P, Slominska EM, Smolenski RT, Polanska J, Rutkowski T, Mrochem-Kwarciak J, Skladowski K, Widlak P. Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients-Comparison of Serum Metabolome Profiles. Metabolites 2020;10:E60. [PMID: 32046123 DOI: 10.3390/metabo10020060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
71 Huang D, Bian G, Pan Y, Han X, Sun Y, Wang Y, Shen G, Cheng M, Fang X, Hu S. MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells. Cancer Cell Int 2017;17:32. [PMID: 28265202 DOI: 10.1186/s12935-017-0389-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
72 Li L, Dai K, Li J, Shi Y, Zhang Z, Liu T, Jun Xie, Ruiping Zhang, Liu Z. A Boron-10 nitride nanosheet for combinational boron neutron capture therapy and chemotherapy of tumor. Biomaterials 2021;268:120587. [PMID: 33296793 DOI: 10.1016/j.biomaterials.2020.120587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
73 Tesei A, Arienti C, Bossi G, Santi S, De Santis I, Bevilacqua A, Zanoni M, Pignatta S, Cortesi M, Zamagni A, Storci G, Bonafè M, Sarnelli A, Romeo A, Cavallo C, Bartolazzi A, Rossi S, Soriani A, Strigari L. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer. J Exp Clin Cancer Res 2021;40:89. [PMID: 33673859 DOI: 10.1186/s13046-021-01883-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Frey B, Derer A, Scheithauer H, Wunderlich R, Fietkau R, Gaipl US. Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity. Adv Exp Med Biol 2016;930:151-72. [PMID: 27558821 DOI: 10.1007/978-3-319-39406-0_7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
75 Rodriguez-Ruiz ME, Rodriguez I, Barbes B, Mayorga L, Sanchez-Paulete AR, Ponz-Sarvise M, Pérez-Gracia JL, Melero I. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies. Brachytherapy 2017;16:1246-51. [PMID: 28838649 DOI: 10.1016/j.brachy.2017.06.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
76 Giordano S, Garvey PB, Baumann DP, Liu J, Butler CE. Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Outcomes: Evidence from Propensity Score Analysis. Ann Surg Oncol 2017;24:816-22. [DOI: 10.1245/s10434-016-5603-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
77 Alghamian Y, Abou Alchamat G, Murad H, Madania A. Effects of γ-radiation on cell growth, cell cycle and promoter methylation of 22 cell cycle genes in the 1321NI astrocytoma cell line. Advances in Medical Sciences 2017;62:330-7. [DOI: 10.1016/j.advms.2017.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
78 Aristizabal Prada ET, Orth M, Nölting S, Spöttl G, Maurer J, Auernhammer C. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells. PLoS One 2017;12:e0178375. [PMID: 28542590 DOI: 10.1371/journal.pone.0178375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
79 Lindell Jonsson E, Erngren I, Engskog M, Haglöf J, Arvidsson T, Hedeland M, Petterson C, Laurell G, Nestor M. Exploring Radiation Response in Two Head and Neck Squamous Carcinoma Cell Lines Through Metabolic Profiling. Front Oncol 2019;9:825. [PMID: 31544064 DOI: 10.3389/fonc.2019.00825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
80 Bhatia K, Bhumika, Das A. Combinatorial drug therapy in cancer - New insights. Life Sci 2020;258:118134. [PMID: 32717272 DOI: 10.1016/j.lfs.2020.118134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
81 Powerski M, Drewes R, Omari J, Relja B, Surov A, Pech M. Intra-hepatic Abscopal Effect Following Radioembolization of Hepatic Metastases. Cardiovasc Intervent Radiol 2020;43:1641-9. [PMID: 32808201 DOI: 10.1007/s00270-020-02612-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Frey B, Rückert M, Deloch L, Rühle PF, Derer A, Fietkau R, Gaipl US. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. Immunol Rev 2017;280:231-48. [PMID: 29027224 DOI: 10.1111/imr.12572] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 19.3] [Reference Citation Analysis]
83 Montelius M, Spetz J, Jalnefjord O, Berger E, Nilsson O, Ljungberg M, Forssell-Aronsson E. Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor. Transl Oncol 2018;11:193-204. [PMID: 29331677 DOI: 10.1016/j.tranon.2017.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
84 Tortora M, Cordelli E, Sicilia R, Miele M, Matteucci P, Iannello G, Ramella S, Soda P. Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma. Artif Intell Med 2021;119:102137. [PMID: 34531006 DOI: 10.1016/j.artmed.2021.102137] [Reference Citation Analysis]
85 Grapin M, Richard C, Limagne E, Boidot R, Morgand V, Bertaut A, Derangere V, Laurent PA, Thibaudin M, Fumet JD, Crehange G, Ghiringhelli F, Mirjolet C. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination. J Immunother Cancer. 2019;7:160. [PMID: 31238970 DOI: 10.1186/s40425-019-0634-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
86 Koka K, Verma A, Dwarakanath BS, Papineni RV. Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment. CMAR 2022;Volume 14:1421-9. [DOI: 10.2147/cmar.s351744] [Reference Citation Analysis]
87 Derer A, Deloch L, Rubner Y, Fietkau R, Frey B, Gaipl US. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015;6:505. [PMID: 26500646 DOI: 10.3389/fimmu.2015.00505] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
88 Nguemgo Kouam P, Bühler H, Hero T, Adamietz IA. The increased adhesion of tumor cells to endothelial cells after irradiation can be reduced by FAK-inhibition. Radiat Oncol 2019;14:25. [PMID: 30717801 DOI: 10.1186/s13014-019-1230-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
89 Anand S, Chan TA, Hasan T, Maytin EV. Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review). Pharmaceuticals (Basel) 2021;14:447. [PMID: 34068491 DOI: 10.3390/ph14050447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
90 Summerer I, Hess J, Pitea A, Unger K, Hieber L, Selmansberger M, Lauber K, Zitzelsberger H. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells. BMC Genomics 2015;16:654. [PMID: 26328888 DOI: 10.1186/s12864-015-1865-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
91 Kultova G, Tichy A, Rehulkova H, Myslivcova-Fucikova A. The hunt for radiation biomarkers: current situation. Int J Radiat Biol 2020;96:370-82. [PMID: 31829779 DOI: 10.1080/09553002.2020.1704909] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
92 Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, Lumniczky K, Polozov S, Napieralska A, Widlak P, Gaipl US, Badie C, Polanska J, Candéias SM. Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy. Strahlenther Onkol 2020;196:1018-33. [PMID: 32519025 DOI: 10.1007/s00066-020-01637-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
93 Mei J, Böhland C, Geiger A, Baur I, Berner K, Heuer S, Liu X, Mataite L, Melo-Narváez MC, Özkaya E, Rupp A, Siebenwirth C, Thoma F, Kling MF, Friedl AA. Development of a model for fibroblast-led collective migration from breast cancer cell spheroids to study radiation effects on invasiveness. Radiat Oncol 2021;16:159. [PMID: 34412654 DOI: 10.1186/s13014-021-01883-6] [Reference Citation Analysis]
94 Lin X, Zeng T, Xiong J, Zhang Q, Jiang P, Li X, Lin S, Xu Q, Weng H, Lai H, Gong H, Lin J, Cheng N, Tian X, Xu Y, Fang S, Jin R, Chen Z, Yang J, Morton L, Yueh B, Lin J. Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma. Cancer Biol Ther 2019;20:666-79. [PMID: 30572778 DOI: 10.1080/15384047.2018.1550569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]